Effect of zinc supplementation on the improvement of gastroesophageal reflux symptoms

Effect of zinc supplementation on the improvement of gastroesophageal reflux symptoms in patients referred to gastroentrology clinic

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201305281155N16

Enrollment

140

Registered

2014-09-02

Start date

2013-12-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease. Gastroesophageal reflux disease

Interventions

Intervention 1: Intervention group take tab pantoprazole 40 miligram one number daily, cap zinc sulfate 220 miligram one number daily during two months. Intervention 2: Control group take tab pantopra

Treatment - Drugs

Intervention group take tab pantoprazole 40 miligram one number daily, cap zinc sulfate 220 miligram one number daily during two months

Control group take tab pantoprazole 40 miligram one number daily, cap zinc placebo one number daily during two months

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: The patients who referred to gastroentrology clinic and based on history, physical exams and frequency scale for the symptoms of gastroesophageal reflux disease questionnaire are diagnosed gastroesophageal reflux disease. Exclusion criteria: Age below 18 years old; pregnant; history of peptic ulcers; patients who have undergone abdominal surgery for any reason

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Gastroesophageal reflux disease treatment. Timepoint: 3 months. Method of measurement: Frequency scale for the symptoms of gastroesophageal reflux disease questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarahnaz Joukar

Gastrointestinal and liver disease research center

f_jokar@gums.ac.ir+98 13 1553 5116

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026